Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer
European Radiology · 19.11.2026
DOI: 10.1007/s00330-026-13085-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Radiology, online erschienen am 19.11.2026. Verfasst von Wei Weng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. shuyi2007@wmu.edu.cn.
Zitieren
APA
Weng, W., & Chen, J. (2026). Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer. European Radiology. https://doi.org/10.1007/s00330-026-13085-3
Vancouver
Weng W, Chen J. Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer. European Radiology. 2026. doi:10.1007/s00330-026-13085-3
BibTeX
@article{Weng2026,
author = {Weng, Wei and Chen, Jinchun},
title = {Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer},
journal = {European Radiology},
year = {2026},
doi = {10.1007/s00330-026-13085-3}
}
EUVIMED